Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

Clinical trial NCT06266091 · COMPLETED

Trial details

NCT number: NCT06266091
Sponsor: Wuhan YZY Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Ascites

Start date: 2021-11-24
Primary completion: 2024-02-14
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.